SULAR
- Product NDC
- 59630-500
- 11-digit product format
- 596300500
- Labeler code
- 59630
- Product ID
- 59630-500_afb5a339-f18f-4850-8041-24859b814174
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nisoldipine
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Shionogi Inc.
- Application
- NDA020356
- Marketing category
- NDA
- Marketing start
- 1995-02-02
- Marketing end
- 0000-00-00
- Substance
- NISOLDIPINE
- Active strength
- 9 mg/1
- Pharmacologic classes
- Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Calcium Channel Antagonists [MoA],Decreased Blood Pressure [PE]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 59630-500 | D | Discontinued by firm | 2026-10-05 | ||
| excluded package | package | 59630-500 | 59630-500-10 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 59630-500-10 | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 59630-500-10 | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 59630-500-10 | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 59630-500-10 | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 59630-500-10 | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 59630-500-10 | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 59630-500-10 | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 59630-500-10 | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 59630-500-10 | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 59630-500-10 | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 59630-500-10 | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 59630-500-10 | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded product | product | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… | |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 59630-500-10 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020356-001 | SULAR | NISOLDIPINE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | |
| N020356-002 | SULAR | NISOLDIPINE | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | |
| N020356-003 | SULAR | NISOLDIPINE | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | |
| N020356-004 | SULAR | NISOLDIPINE | 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | |
| N020356-005 | SULAR | NISOLDIPINE | 34MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-01-02 | |
| N020356-006 | SULAR | NISOLDIPINE | 25.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-01-02 | |
| N020356-007 | SULAR | NISOLDIPINE | 17MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-01-02 | |
| N020356-008 | SULAR | NISOLDIPINE | 8.5MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-01-02 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020356-008 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N020356-001 | SULAR | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020356-002 | SULAR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020356-003 | SULAR | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020356-004 | SULAR | 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020356-005 | SULAR | 34MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-01-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020356-006 | SULAR | 25.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-01-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020356-007 | SULAR | 17MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-01-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020356-008 | SULAR | 8.5MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-01-02 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N020356-001 | SULAR | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020356-002 | SULAR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020356-003 | SULAR | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020356-004 | SULAR | 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020356-005 | SULAR | 34MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-01-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020356-006 | SULAR | 25.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-01-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020356-007 | SULAR | 17MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-01-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020356-008 | SULAR | 8.5MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-01-02 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020356-001 | SULAR | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020356-002 | SULAR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020356-003 | SULAR | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020356-004 | SULAR | 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020356-005 | SULAR | 34MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-01-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020356-006 | SULAR | 25.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-01-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020356-007 | SULAR | 17MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-01-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020356-008 | SULAR | 8.5MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-01-02 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020356-001 | SULAR | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020356-002 | SULAR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020356-003 | SULAR | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020356-004 | SULAR | 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020356-005 | SULAR | 34MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-01-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020356-006 | SULAR | 25.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-01-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020356-007 | SULAR | 17MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-01-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020356-008 | SULAR | 8.5MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-01-02 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020356-001 | SULAR | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020356-002 | SULAR | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020356-003 | SULAR | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020356-004 | SULAR | 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1995-02-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020356-005 | SULAR | 34MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-01-02 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020356-006 | SULAR | 25.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-01-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020356-007 | SULAR | 17MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-01-02 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020356-008 | SULAR | 8.5MG | TABLET, EXTENDED RELEASE / ORAL | AB | RLD, RS | 2008-01-02 | 6a471c1ec25d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N020356-008 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N020356-008 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020356-005 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020356-007 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020356-008 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020356-005 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020356-007 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020356-008 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020356-005 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020356-007 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020356-008 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020356-005 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020356-007 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020356-008 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020356-005 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020356-007 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020356-008 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020356-005 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020356-007 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020356-008 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020356-005 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020356-007 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020356-008 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020356-005 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020356-007 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020356-008 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020356-005 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020356-007 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020356-008 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N020356-005 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N020356-007 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N020356-008 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020356-005 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020356-007 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020356-008 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020356-005 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020356-007 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020356-008 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020356-005 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020356-007 | AB | 1 | 1e350fbaab3a… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59630-500-10 | EA - Each | 59630-500 | 22d5bf1c-eea6-4f98-b669-ea49e9f014a0 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sular | NISOLDIPINE | Covis Pharma US, Inc | 589157fa-d129-4de3-be3d-e0e1c22c5873 | 2026-03-12 | Warnings, Adverse reactions | 020356 NDA020356 |
| Nisoldipine | NISOLDIPINE | Prasco Laboratories | 8a5fb6a2-9fae-4872-8c5c-0f1ba03a57cb | 2021-10-01 | Warnings, Adverse reactions | 020356 NDA020356 |